Company page

Ocugen, Inc.

Ocugen, Inc. is a public company traded under the ticker OCGN in the American market. With a market capitalization of approximately $419.77 million, Ocugen focuses on developing innovative therapies to address unmet medical needs. The company is committed to advancing its pipeline and expanding its presence in the biopharmaceutical sector.